Biocon Secures Multiple Market Access Agreements For Yesintek
Biocon Secures Multiple Market Access Agreements For Yesintek
Clinical studies showed that Yesintek is a biosimilar to Stelara and has similar pharmacokinetic, safety, efficacy and immunogenicity profile compared with Stelara. Yesintek…